We constantly express our gratitude but let us take this wonderful opportunity to do so again…

We deeply thank all of our friends, fans, supporters, donors, sponsors, partners, collaborators, subscribers, followers who make our life happier by helping us serve everyone in, oftentimes heartbreaking, need for trusted cancer information they can understand and guidance for centers and hospitals through our Patient Platform, and brilliant young students who seek scientific career guidance through our CRS Youth Program worldwide every day.

We are grateful for each and everyone of you!

Happy Thanksgiving!
Your CRS Family 
‪
#‎Thanksgiving‬ ‪#‎happythanksgiving‬

For immediate release
November 17, 2015
 
Cancer Scientist CEO of Nonprofit ‘Simplifies’ All Aspects of Prostate Cancer at its Sponsored Lecture
 
Brookline, Mass…. Cancer Research Simplified (CRS)’s cancer scientist CEO and Founder, Ayguen Sahin, MSc, PhD gave a full lecture on prostate cancer at its fourth sponsored public cancer lecture held on November 10th, 2015 at the Brookline Public Library in Brookline, MA.
 
Award-winning cancer scientist, Dr. Ayguen Sahin’s passion in cancer education and bringing science “down” to people, thus bridging the gap between cancer scientists and cancer patients, made her found two and a half years ago the Boston-based, global nonprofit organization on cancer education, Cancer Research Simplified (CRS), aiming to communicate scientific research in a simplified, non-technical way and in multiple languages to cancer patients and the general public around the globe.
 
“During my doctoral work and research in Germany and postdoctoral fellowship and faculty membership at Massachusetts General Hospital/Harvard Medical School, I felt a growing gap between cancer scientists and cancer patients and thus, the need of bridging this gap.” Dr. Sahin founded Cancer Research Simplified (CRS) in January 2013, which earned several awards in 2014, including winning twice in a row the Top-Rated Nonprofit Award by Great Nonprofits in 2014 and 2015 based on the votes and reviews of the public.
 
Dr. Sahin provided a full prostate cancer lecture as the fourth lecture in the Cancer Symposium Series 2015 of CRS.  Sponsored by Genentech, Boston Thermography Center, The Print House, MBTA, Life Alive Organic Café, Flatbread Company, Iggy’s Bread, J.P. Licks, and Trader Joe’s, with the volunteering help of Jamie at BWH/HMS and CRS team member and volunteer at the event, BusraYilmaz, the lecture provided simplified, factual information on prostate cancer prevention and early detection, screening, current treatment strategies, clinical trials, new research and drug approvals, life after survival, and nutritional facts.
 
“While educating the public on all types of cancer through our educational videos on YouTube and our written materials on our website for the past two and a half years, we know now the ‘exact’ way of simplifying the educational materials we write for our audience to be able to understand,” said Dr. Sahin. “I was more than pleased to see that lecture was extremely well received, and left a big smile on attendees’ faces, having learned so many valuable information on prostate cancer and the info I shared with them on cancer prevention on daily basis. The ‘solely highly positive’ reviews we have gotten after the lecture was exceptionally rewarding, knowing that we truly helped people – and that’s what we’re working for!”
 
The audience included cancer patients, family members, general public, and patients on active surveillance. “I will be conscious of maintaining my exercise, supplementation, and nutrition program,” said one attendee when asked what they would do differently as a result of attending the program. Another attendee responded, “I will get a PSA test and try to eat better diet and get more exercise,” while another responded as “I will be focusing on my active surveillance.”  Impressed by the lecture, one of the attendees praised the lecturer, Dr. Sahin, "You really are a scientist who "knows her stuff “." 

CEO and Founder of Cancer Research Simplified, Ayguen Sahin, MSc, PhD, provides lecture on prostate cancer at its Cancer Symposium Series. 

1st and 2nd winners of CRS’s Cancer Quiz Game receive their prizes from Dr. Ayguen Sahin, CEO and Founder of
Cancer Research Simplified.

CRS’s much-loved game at all of its events, the CRS Cancer Quiz Game™, found its 1st, 2nd, and 3rd prize winners after the lecture, while the 2nd prize was shared between two winners. “Like the Colon Cancer Lecture I gave back in July, I was truly amazed that not only we have gotten the 1st prize winner who have had 10 right out of ten questions, but also that we have gotten two 2nd prize winners who have had 9 right out of ten questions, which showed how us how well the information provided was understood,” said Dr. Sahin.
 
Pictures on it’s website, http://www.cancerresearchsimplified.org/events.html
and on its Facebook Fan Page, https://www.facebook.com/CancerResearchSimplified 
 
This fourth lecture herewith completes the series of CRS’s Public Cancer Symposium, held on breast, lung, colon, and prostate cancer throughout the year.
 
About Cancer Research Simplified:
Cancer Research Simplified (www.CancerResearchSimplified.org) is an independent, 501(c)(3) global non-profit organization. Its three-fold mission is to provide simplified information about cancer and cancer research to cancer patients and the general public; to bridge the gap between cancer scientists and cancer patients; and to provide cancer research scholarships for high school students worldwide.
 
Mission Statement
Making cancer research understandable for everyone. Providing scholarships for young students worldwide to encourage careers in cancer research.  
 
Vision
By providing cancer patients with information about their disease, up-to-date research, and specialized cancer treatment institutes, we can bridge the gap between cancer patients and cancer-treatment professionals and ease the burden on cancer patients by making it easy to find the best possible care.
 
Contact Dr. Ayguen Sahin, Chief Executive Officer, at info(at)cancerresearchsimplified.org for further information.
 
###

For Immediate Release:

CANCER RESEARCH SIMPLIFIED HONORED AS 2015 TOP-RATED NONPROFIT  GreatNonprofits.org Award is based on positive online reviews

​Cambridge, Massachusetts November 4, 2015 – Cancer Research Simplified announced today that it has been honored with a prestigious 2015 Top-Rated Award by GreatNonprofits, the leading provider of user reviews about nonprofit organizations.

​“We are very excited to be named a Top-Rated Nonprofit for the second time in a row, and deeply honored to see that we make a true difference in people’s lives” says Dr. Ayguen Sahin, CEO and Founder of Cancer Research Simplified. “We are proud of our accomplishments this year, including the launch of our Online Store that includes CRS products as well as my mother’s handmade cancer awareness carves, sent all the way from Turkey; the launch of our Russian and Portuguese educational programs, totaling our program languages to eight; being invited to meet with Consul General of Turkey in Boston; partnering up with Boston Thermography Center in enhancing breast health education; our partnership with Cambridge College; our fundraiser bike ride; publishing many educational videos and new research articles through our online journal (JSCR), website, and YouTube channel; launching our Patient Platform in English, German, and Turkish, helping many patients and family members worldwide by giving guidance on latest research, cancer centers and hospitals, healthy lifestyle, diet, and other aspects; and the launch of our CRS Cancer Symposium and Lecture series 2015 on breast, lung, colon, prostate cancer, the latter of which is coming up on November 10, sponsored by Genentech, Boston Thermography Center, The Print House, Massachusetts Bay Transportation Authority (MBTA), Cambridge College, Life Alive Organic Café, J.P. Licks, Flatbread Company, Iggy’s Bread, Trader Joe’s, with kind help in artwork by Jamie Bell at Brigham and Women’s Hospital/Harvard Medical School.”

The Top-Rated Nonprofit Award was based on the large number of positive reviews that Cancer Research Simplified received –written by volunteers, donors, and clients, who posted their personal experience with the nonprofit. Emma, for example, wrote: “Cancer Research Simplified provides us the information we need and looking for in a way that we can reach easily and understand. Also, I find the symposiums they have been organizing are informative and help to find answers to the questions I have in my mind about cancer types and treatments.” Sinan from Canada wrote: “I have had the privilege of working with CRS for the past couple years. They are one of the very best nonprofit organizations out there. Each and every volunteer was working very hard to provide the latest information and guidance to the cancer patients. They helped thousands of cancer patients diagnosed with various types cancer with their online web site and forums, meetings and activities by bringing attention to cancer awareness. I was very lucky to work with Ayguen Sahin, the founder of CRS, and very grateful to all the wonderful volunteers who make this very great organization that it is.” Cancer Research Simplified earned this award with a remarkable rating of 4.93 out of 5 stars.

While the Top-Rated Awards run through the end of October, Cancer Research Simplified was part of the inaugural group to qualify for the year. In addition, Cancer Research Simplified will been added to GreatNonprofits’ #GivingTuesday guide – an interactive guide on top nonprofits throughout the years. Look out for this around the holidays.

“Savvy donors want to see the impact of their donations more than ever,” said Perla Ni, CEO of GreatNonprofits, “People with direct experience with Cancer Research Simplified have voted that the organization is making a real difference.”

​Being on the Top-Rated list gives donors and volunteers more confidence that this is a credible organization. The reviews by volunteers, clients and other donors show the on-the-ground results of this nonprofit. This award is a form of recognition by the community. More reviews of Cancer Research Simplified can be read and added here: http://greatnonprofits.org/org/cancer-research-simplified

About Cancer Research Simplified
Cancer Research Simplified (www.CancerResearchSimplified.org) is an independent, 501(c)(3) global nonprofit organization. Its mission is to 1.) provide simplified information about cancer and cancer research to cancer patients and the general public, 2.) bridge the gap between cancer scientists and cancer patients; and 3.) provide cancer research scholarships for high school students worldwide.
Mission Statement
Making cancer research understandable for everyone. Providing scholarships for young students worldwide to encourage careers in cancer research.  
Vision
By providing cancer patients with information about their disease, up-to-date research, and specialized cancer treatment institutes, we can bridge the gap between cancer patients and cancer-treatment professionals and ease the burden on cancer patients by making it easy to find the best possible care.

About GreatNonprofits
GreatNonprofits is the leading site for donors and volunteers to find reviews and ratings of nonprofits. Reviews on the site influence 30 million donation decisions a year. Visit www.greatnonprofits.org for more information.

Media Contact
Ayguen Sahin, MSc, PhD, CEO and Founder, Cancer Research Simplified; info@cancerresearchsimplified.org
###

​November is ‪Pancreatic Cancer Awareness Month‬! We deeply acknowledge our heroes & heroines! 

Did you know that FDA approved a new treatment for advanced pancreatic cancer on October 22, 2015? 

Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, was approved by the FDA (The U.S. Food and Drug Administration) to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy.

The FDA granted Priority Review and orphan drug designations for Onivyde. Priority review status is granted to applications for drugs that, if approved, would be a significant improvement in safety or effectiveness in the treatment of a serious condition.

Read more about this approval here.

#‎PancreaticCancerAwarenessMonth‬ ‪#‎pancreaticcancer‬ ‪#‎cancerresearch‬ ‪#‎fda‬ ‪#‎fdaapproval‬ ‪#‎onivyde‬ ‪#‎advancedpancreaticcancer‬‪ #‎metastaticpancreaticcancer‬